ExacTrac surface guidance shortens breast RT setup without significantly improving positioning accuracy

Surface-guided breast RT shortened preparation time by approximately three minutes without significantly improving initial positioning accuracy compared with tattoos.

KEY POINTS

  • This retrospective single-center study from Shaare Zedek Medical Center, Israel, compared ExacTrac Dynamic surface-guided radiotherapy (SGRT) with conventional tattoo-based positioning in 69 patients receiving breast radiotherapy between December 2022 and December 2024. The SGRT cohort comprised 49 patients and 245 fractions, while 20 patients and 100 fractions formed the tattoo-based control group. All patients underwent breast-conserving surgery and received 26 Gy in five fractions, without regional nodal irradiation or tumor-bed boost, using deep inspiration breath-hold (DIBH) and identical immobilization protocols.
  • Initial patient positioning was performed using either three-dimensional surface registration with ExacTrac Dynamic or conventional alignment of skin tattoos with room lasers. Both groups subsequently underwent daily orthogonal kilovoltage imaging, with couch corrections applied before irradiation. Setup accuracy was therefore assessed using six-dimensional pre-correction deviations relative to kV imaging, rather than final treatment-position accuracy. Statistical analysis accounted for clustering of repeated fractions within patients, with intraclass correlation coefficients reaching 0.75.
  • Initial setup accuracy did not differ significantly between SGRT and tattoo-based positioning in any evaluated direction. Mean absolute vertical deviations were 7.90 versus 6.58 mm (p=0.264), longitudinal deviations 7.61 versus 5.94 mm (p=0.119), and lateral deviations 3.09 versus 3.87 mm (p=0.110), respectively. Composite translational (p=0.270) and rotational (p=0.697) errors were also similar, as were three-dimensional displacement vectors (12.5 versus 11.1 mm; p=0.29). The absence of statistically significant differences does not establish formal equivalence.
  • SGRT demonstrated a systematic vertical positioning offset relative to kV imaging. The mean signed vertical deviation was approximately −4.8 mm with SGRT versus +0.3 mm with tattoos, corresponding to a between-group difference of −5.1 mm (95% CI −8.9 to −1.3 mm; nominal p=0.013). However, this association did not remain statistically significant after Bonferroni correction for six axes (adjusted p=0.078). Potential contributors include differences between external surface registration and internal bony anatomy, DIBH variability, breast deformation, reference-surface selection, and surface ROI configuration.
  • Clinically significant pre-correction deviations of at least 5 mm remained frequent with both techniques. Vertical deviations exceeded this threshold in 64.9% of SGRT versus 52.0% of tattoo-based fractions, while longitudinal deviations occurred in 64.9% versus 53.0%, respectively; lateral deviations were less frequent with SGRT (20.4% vs 31.0%). kV-based corrections were required in 98% of SGRT fractions and 100% of tattoo-based fractions. These findings support continued daily image verification and do not justify reducing PTV margins based on initial SGRT positioning alone.
  • Treatment preparation time was significantly shorter with SGRT. Mean time from patient registration in the treatment room to acquisition of the first kV verification image decreased from 13.9 minutes with tattoo-based positioning to 11.0 minutes with SGRT (p=0.036), representing approximately 2.9 minutes saved per treatment session. Median preparation time decreased from 12.5 to 10.0 minutes, with no significant learning-curve association. However, these measurements were available for 48 SGRT and 20 control patients, were recorded only once per patient, and excluded kV-based couch correction and beam delivery.
  • The study did not evaluate a fully tattoo-free workflow. All SGRT patients also received permanent skin tattoos during simulation as a backup, although these were not used for routine daily positioning. The nonrandomized cohorts were relatively small and unmatched, and no equivalence margin was predefined. Furthermore, post-correction positioning accuracy, intrafraction motion, DIBH reproducibility, dosimetric consequences, clinical toxicity, and patient-reported satisfaction were not evaluated, limiting conclusions about the broader clinical or psychological advantages of surface guidance.

CLINICAL TAKEAWAY

ExacTrac Dynamic surface guidance can reduce preparation time during breast radiotherapy while providing initial positioning accuracy that was not statistically different from conventional tattoo-based alignment in this small retrospective cohort. However, clinically relevant pre-correction deviations remained common, a vertical offset was observed, and daily kV verification was still necessary; the results support further evaluation of tattoo-independent workflows but do not establish safe omission of tattoos or image guidance.

SOURCE

Cancers

Browse more research Suggest a correction